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Abstract.  The Saccharomyces  cerevisiae APE1 gene 
product, aminopeptidase I (API), is a soluble hydro- 
lase that has been shown to be localized to the vac- 
uole. API lacks a standard signal sequence and con- 
tains an unusual amino-terminal propeptide. We have 
examined the biosynthesis of API in order to elucidate 
the mechanism of its delivery to the vacuole. API is 
synthesized as an inactive precursor that is matured in 
a PEP4-dependent  manner. The half-time for process- 
ing is approximately 45 min. The API precursor re- 
mains in the cytoplasm after synthesis and does not 
enter the secretory pathway, The precursor does not 
receive glycosyl modifications, and removal  of its pro- 
peptide occurs in a sec-independent  manner. Neither 
the precursor nor mature form of API are secreted into 
the extracellular fraction in Ws mutants or upon over- 
production, two additional characteristics of soluble 
vacuolar proteins that transit through the secretory 
pathway. Overproduction of API results in both an in- 
crease in the half-time of processing and the stable ac- 
cumulation of precursor protein. These results suggest 
that API enters the vacuole by a posttranslational 
process not used by most previously studied resident 
vacuolar proteins and will be a useful model protein 
to analyze this alternative mechanism of vacuolar 
localization. 
I 
N the  yeast Saccharomyces cerevisiae, the vacuole  is 
integrally involved in a wide array of physiological pro- 
cesses  (reviewed in Klionsky et al.,  1990). These in- 
clude pH and osmoregulation, protein degradation and stor- 
age of amino acids,  small ions, and polyphosphate.  These 
diverse functions necessitate the presence in the vacuole of 
a specific group of proteins. As with all organelles, accurate 
and efficient delivery of  the resident proteins is critical to that 
organelle's ability to carry out its designated role(s) in cellu- 
lar metabolism.  In a general sense, proteins arrive at most 
organelles through one of two primary routes: the proteins 
either remain in the cytoplasm after being synthesized and 
are translocated directly into the organelle, or they enter the 
secretory pathway and are delivered to subsequent organelles 
via vesicular intermediates.  The vacuole is perhaps unique 
in that protein  targeting to this organeUe employs both of 
these processes.  All but one of the characterized  vacuolar 
proteins transit through a portion of the secretory pathway 
before being directed to the vacuole (Klionsky et al., 1990). 
This mechanism of  vacuolar delivery has been carefully ana- 
lyzed although  many questions  remain to be resolved.  In 
general, proteins are cotranslationally  translocated into the 
ER due to the presence of  an amino-terminal signal sequence. 
These proteins transit to the Golgi complex, undergoing vari- 
ous glycosyl and/or proteolytic modifications. At the trans 
Golgi network, they are separated from other proteins utiliz- 
ing the secretory pathway and are directed to the vacuole. 
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In contrast,  the vacuolar  hydrolase  ot-mannosidase ap- 
pears  to  enter  the  vacuole  directly  from  the  cytoplasm 
(Yoshihisa and Anraku, 1990). Some proteins destined for 
degradation,  such as fructose 1,6-bisphosphatase, may also 
enter the vacuole in this manner (Funaguma et al.,  1985; 
Chiang and Schekman,  1991), although the specific mecha- 
nism in either case has not been elucidated. In addition, pro- 
teins may be delivered to the vacuole from the cell surface 
via endocytosis.  The best  studied  example of this  is  the 
PEP4-dependent turnover of  a-factor (Chvatchko  et al., 1986; 
Jermess and Spatrich,  1986; Payne et al., 1988; Singer and 
Riezman,  1990). It is not known if other proteins are deliv- 
ered to the vacuole in this way. At present, many aspects of 
these  different targeting  mechanisms  have not  been  well 
characterized. 
Many analyses of vacuolar protein biosynthesis and sort- 
ing were initiated through the identification of protease ac- 
tivities corresponding to this organelle. The use of  a wide va- 
riety of substrates has allowed the characterization  of over 
eight  different  vacuolar  hydrolases  (Jones, 1984; Suarez 
Rendueles and Wolf, 1988; Klionsky  et al., 1990). There are 
four identified aminopeptidases in Saccharomyces cerevisiae 
that  hydrolyze  leucine  substrates  (Trumbly  and  Bradley, 
1983).  Of these,  only aminopeptidase  I  (API;  previously 
designated LAPIV) ~  appears to be localized to the vacuole 
based on subcellular fractionation (Matile et al., 1971; Frey 
and R6hm,  1978). Initial studies of API characterized  it as 
being  a glycoprotein  containing  12%  carbohydrate  (Metz 
1. Abbreviations  used in this paper: API, aminopeptidasc I; TX-100, Triton 
3:-100; YNB, yeast nitrogen base; YPD,  1% bacto-yeast extract, 2% bacto- 
peptone, 2% dextrose. 
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sized as an inactive zymogen that was processed in a PEP4- 
dependent manner (Trumbly and Bradley,  1983;  Cueva et 
al.,  1989;  Chang  and Smith,  1989)  like all other soluble 
vacuolar proteins that transit through the secretory pathway 
(Klionsky et al., 1990). The gene encoding API, APE/(pre- 
viously designated LAP4), has been cloned and the nucleo- 
tide sequence determined (Cueva et al.,  1989;  Chang and 
Smith,  1989).  The APE/  gene codes for a  protein of 514 
amino  acids  containing  four potential  sites  for  N-linked 
glycosylation. Amino acid sequence analysis of the mature 
protein indicated the presence of a 45-residue propeptide. 
The propeptide of API,  however, does not contain a  con- 
sensus signal sequence cleavage site. Furthermore, it lacks 
any homology to a standard signal sequence because it is not 
hydrophobic. Instead, a region of the amino terminus has the 
characteristics of  an amphiphilic o~-helix (Cueva et al., 1989; 
Chang and Smith,  1989). 
API was presumed to transit through the secretory path- 
way  because  it  appeared  to  be  glycosylated.  The  initial 
studies regarding glycosylation, however, were not conclu- 
sive. The active enzyme is a multimeric protein having a mo- 
lecular mass of ~600,000 D. The mature API monomer has 
a  molecular mass  of 50,000-51,000  D  based  in  part  on 
migration in SDS-PAGE (Metz and R/Shm, 1976; Chang and 
Smith,  1989). The molecular mass based on the amino acid 
composition,  however,  predicts  a  protein  of '~45,000  D 
(Metz and Rfhm, 1976). This fact coupled with carbohydrate 
analyses led Metz and R/Shm to assume that the additional 
5 kD were derived from oligosaccharides. The presence of 
carbohydrate was not confirmed, however, by treatment with 
tunicamycin or binding to carbohydrate-specific lectins. To 
resolve these questions and to further characterize the nature 
of this protein, we have carried out a detailed immunological 
analysis of the biosynthesis and  sorting of API.  We have 
found that API is not glycosylated and does not enter the 
secretory  pathway.  The  API  precursor  remains  in  the 
cytoplasm and appears to translocate directly into the vacu- 
ole with a half-time of "~45 min. These results indicate that 
API may enter the vacuole by a mechanism that is unique 
from that used by almost all of the characterized vacuolar 
proteins. 
Materials and Methods 
Strains and Media 
The Saccharomyces  cerevisiae yeast strains used in this study are listed in 
Table I. Strains NAYII-17 and NAYIII-1 were generated from a cross be- 
tween strain 1189 (Trumbly and Bradley, 1983) and strain DBY746 (Garcia- 
Alvarez  et al.,  1991). The  vps  mutants used are derivatives  of strains 
SEY6210 (vps5-7, 1%9) or SEY6211 (vpsl-3, 8-30, 15-14, 26-8) (Robinson 
et al.,  1988).  Strain BJ3044 was generously  supplied  by Elizabeth Jones 
(Carnegie Mellon University, Pittsburgh, PA). Standard methods (Sherman 
et al.,  1979) were used to construct yeast strain DYY101 (see below). 
YPD medium (1% bacto-yeast extract, 2 % bacto-peptone, 2 % dextrose; 
Sherman et al.,  1979), modified Wickerham's minimal medium containing 
0.2% yeast extract (Robinson et al., 1988), and yeast nitrogen base (YNB) 
medium with the appropriate supplements were used for growing yeast. 
Reagents 
Lyticase  was obtained from Enzogenetics  (Corvallis,  OR),  Tran35S-label 
was from ICN Radiochemicals  (Irvine, CA), DNA restriction and modify- 
ing enzymes were from New  England Biolabs,  Inc.  (Beverly,  MA), c~2- 
m.acroglobulin was from Boehringer Mannheim Biocbemicals (Indianapolis, 
IN),  L-leucine/3-naphthylamide  was from Bachem (Philadelphia, PA), and 
Autofluor was from National Diagnostics,  Inc.  (Manville,  NJ). SP6 poly- 
merase, RNasin ribonuclease inhibitor and rNTPs were from Promega Bio- 
tec (Madison, WI). All other chemicals were from Sigma Chemical Co. (St. 
Louis,  MO). Wheat germ lysate was generously supplied  by William Et- 
tinger and Steven Theg (Department of Botany,  University of California, 
Davis). Antisera to PrA, CPY, and ALP were prepared as described previ- 
ously (Klionsky et al., 1988; Klionsky and Emr,  1989). To produce antise- 
rum to API, we had two synthetic peptides made (Multiple Peptide Systems, 
San Diego,  CA) based on the deduced amino acid sequence of the APE/ 
gene. Peptides corresponding to amino acid residues 168-182 and 191-212 
of API were separately conjugat~l at their COOH termini to keyhole limpet 
hemocyanin.  Standard procedures were used to generate antiserum in New 
Zealand White rabbits. 
Table L  Yeast Strains 
Yeast strains  Genotype  Source 
BJ3044  MATa canl  lys2-801  prbl-A1.6 ura3-52  Moehle et al.,  1989 
DBY746  MATer leu2-3,112 his31 ura3-52  Yeast Genetic Stock 
trpl-289  Center 
DYY101  MATct leu2-3,112 ura3-52 his3-A200  This study 
trpl-A901 ade2-101  suc2-A9 GAL 
ape 1 :: LEU2 
NAYII-17  MATc~ lapl  lap2 lap3 lap4 leu2-3,112  N.  Garcia-Alvarez 
his3-A1 ura3-52 trp1-289  (University of Oviedo) 
NAYIII-1  MATa lapl  lap2 lap3 leu2-3,112  N.  Garcia-Alvarez 
his3-A1 ura3-52 
SEY2101  MATa leu2-3,112 ura3-52 ade2-1  Emr et al.,  1983 
suc2-A9 
SEY2101Apep4  MATa leu2-3,112 ura3-52 ade2-1  Klionsky et al.,  1988 
suc2-A9 Apep4::LEU2 
SEY5187  MATa secl8-1  1eu2-3,112 ura3-52  Klionsky et al.,  1988 
suc2-A9 
SEY6210  MATa leu2-3,112 ura3-52 his3-A200  Robinson et al.,  1988 
trpl-A901  lys2-801  suc2-A9 GAL 
SF274-3A  MATc~ gal2 secl2-4  C.  Field and R.  Schekman 
(University of California, 
Berkeley) 
SF309-2C  MATc~ gal2 sec23-1  C.  Field and R.  Schekman 
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The APE/gene was cloned by complementation  of the lap4 mutation as de- 
scribed previously  (Cueva  et al.,  1989).  One of the multicopy number 
(2# circle) complementing plasmids, pRCI,  contains a  4.75-kb BamHI 
fragment encoding APE/, cloned into the plasmid YEpl3 (Nasmyth and 
Tatchell,  1980).  The centromeric (CEN4 ARS1) plasmid pRN1 was con- 
strutted by cloning a 4.5-kb SpM fragment encoding the entire APE/gene 
from pRC1 into the SphI site of YCp50 (Johnston and Davis,  1984).  To 
carry out in vitro transcription/translation of APE/, a  1.69-kb DNA frag- 
ment containing the APE/gene was amplified using the polymerase chain 
reaction. Oligonucleotides  containing a SalI site before nucleotide -3 and 
a HindlU site starting at nucleotide 1685 of the APE/gene (Cueva et al., 
1989) were used for the reaction. The resulting fragment was ligated into 
pKK4 that had been restricted with Sail and Hindlll. The plasmid pKK4 
was supplied by Thomas Moore and Alan Bennett  (Department  of Vegetable 
Crops,  University of California, Davis).  This plasmid is a derivative of 
pSP65 (Melton et al., 1984) in which the SphI site has been destroyed and 
the polylinker has been replaced with the polylinker from pUC19 (Yanisch- 
Perron et al.,  1985). 
Plasmid pAM1 (Kuranda and Robbins, 1987) encodes c~-marmosidase  on 
a multiple copy vector and was supplied by Dr. Michael Kuranda and Dr. 
Phillips Robbins (Massachusetts Institute of Technology).  The multiple 
copy  plasmids pTSY1 (Stevens  et al.,  1986)  and pPA3 (Rothman et al., 
1986),  encoding CPY and PrA, respectively,  were  supplied  by Dr.  Tom 
Stevens (University of Oregon). 
To disrupt the chromosomal APE/locus, the APE/gene was cloned into 
a derivative  of pUC19 in which the EcoRI site had been destroyed. This was 
performed in two steps as follows:  First, a  1.3-kb amI-lI/SalI fragment 
from pRC1 encoding a COOH-terminal portion of API was cloned into the 
pUC19  derivative.  The  resulting plasmid,  pDSY1,  was  restricted with 
BamHI. Second, a 2.0-kb Baml-lI fragment from pRC1 was ligated into the 
restricted BamHI site of pDSYI to generate plasmid pDSY2 (Fig.  1). This 
plasmid, containing the entire APE/gene, was restricted with EcoRI to re- 
move almost the entire APE/coding region, and the overhanging ends were 
blunted with the Klenow fragment of DNA polymerase I. A XhoI/SalI frag- 
ment containing the LEU2  gene from the plasmid YEpl3 (Nasmyth and 
Tatchell,  1980) was ligated into the blunt-ended EcoRI site of pDSY2 to 
generate the APE/disruption plasmid pDSY3 (Fig.  1). This plasmid was 
linearized with BamHI and SalI and used to transform yeast strain SEY6210 
to generate the chromosomal APE/deletion strain DYY101. 
Cell Labeling and Immunoprecipitation 
The procedures used for the preparation, labeling, fractionation, and immu- 
noprecipitation  of yeast cells and spberoplasts were modifications of proce- 
dures described previously (Klionsky  et al.,  1988; Robinson et al.,  1988; 
Klionsky et al., 1992). Because of the long half-time of processing of API, 
it was necessary to carry out pulse-chase analyses using conditions where 
the cultures were at a relatively low initial density.  This ensured that the 
cells were able to grow throughout the labeling and chase periods.  Gener- 
ally,  cells were labeled at concentrations of 4-50Do00 per ml and then 
diluted to 0.50Dt0o per ml by the addition of fresh medium for the non- 
radioactive chase.  Chase solutions contained methionine (8 mM) and cys- 
teine (4 mM). 
To test for the presence of carbohydrate,  cells were grown to mid-log 
phase  and  separated  into two  cultures.  One  culture  was  treated  with 
tunicamycin (20 ~g/ml final concentration) for 15 min prior to the addition 
of label. Cells were labeled for 30 min and then subjected to a nonradioac- 
tive chase for0 or 120 rain. At the end of the chase, cells were precipitated 
with  "IV.A, washed  with  acetone,  dried,  and  resuspended  in  100  /~1 
MES/urea resuspension  buffer (MURB; 50 mM sodium phosphate, 25 mM 
MES, pH 7.0, 1% SDS, 3 M urea, 0.5% B-mercaptoethanol, 1 mM sodimn 
azide). Each sample was then divided in half and diluted with 800 vl of 
Tween 20 IP buffer (0.5% Tween 20, 50 mM Tris hydrochtoride [pH 7.5], 
150 mM NaC1, 0.1 mM EDTA). One half  was immunoprecipitated with an- 
tiserum to API and CPY (total sample).  The remaining half was diluted 
with 1 ml Con A reaction buffer (20 mM Tris, pH 7.5, 500 mM NaCI,  1% 
Triton X-100 [TX-100]) and precipitated with Con A-sepharose essentially 
as described (Deshaies and Scheknmn, 1987; Baker et al.,  1988).  Con A 
precipitations were carried out using 30 /~1 of packed Con A-sepharose 
beads per sample.  The supernatant fraction from the Con A precipitations 
was boiled for 4 rain, centrifuged to remove insoluble material, and sub- 
jected to immunoprecipitation (supernatant sample). The pellet from the 
Con A precipitations was washed twice with Con A reaction buffer and 
boiled in 100/xl MURB. The pellet samples were then diluted with 1 ml 
Figure 1. Disruption of the APE/locus,  A restriction enzyme map 
is shown of the ,,o3.3-kb genomie DNA fragment of APE/present 
in plasmid pDSY2. The EcoRI fragment from within the APE/cod- 
ing region was removed, and the ends were blunted. An ,-o2.2_kb 
XhoI/SalI fragment encoding the yeast LEU2 gene was blunt-ended 
and  inserted  into  the  deleted  APE/  gene  to  generate  plasmid 
pDSY3. The plasmid pDSY3 was used to disrupt the chromosomal 
APE/locus as described in Materials and Methods. The white box 
represents the APE/gene, and the stippled box represents the LEU2 
coding region. Restriction enzymes are as follows:  B, BamHI; E, 
EcoRI;  S,  SalI. 
Con A reaction buffer and centrifuged, and the resulting supernatant frac- 
tion was immunoprecipitated  with antisera to API and CPY (pellet sample). 
Accessibility  to exogenous protease was used to examine the location of 
precursor and mature API. Because mature API is resistant to proteolysis, 
the location of "mature" API was assessed by using spheroplasts prepared 
from a culture of strain SEY2101 Apep4. Spheroplasts  were labeled for 20 
min and subjected to a 2-min (precursor API) or 135-min ("mature" API) 
chase. After each chase point, the spheroplasts  were centrifuged for 2 min 
at 3,000 rpm in the presence of 10 mM sodium azide. The spheroplast pellet 
was resuspended  in 0.2 M imidazole,  pH 6.5, 0.2 M sorbitol, 15% ficoll 
and gently  lysed  by the addition of DEAE-dextran (Diirr et al.,  1975; 
Klionsky and Emr, 1989). Unlysed spheroplasts  were removed by eentrifu- 
gation.  The supernatant fractions were divided into three aliquots,  two of 
which received either pronase (200 #g/ml) or pronase and TX-100 (0.2%). 
The samples  were incubated at 0~  for 30 min followed by precipitation 
with ~.A. The samples were then immunoprecipitated with antisera to API 
and CPY. 
To examine  whether API is membrane-associated, a culture of strain 
SEY5187 was converted  to spheroplasts and shifted to 37~  for 15 min. The 
spheroplasts were labeled at 32"C for 30 min followed by a nonradioactive 
chase for 30 rain. The spheroplasts  were pelleted by centrifugation and 
lysed by resuspension in 1.5 ml oflysis buffer (50 mM potassium phosphate, 
pH  Z5,  10 mM  sodium azide,  100  t~g/ml tx2-macroglobulin).  Samples 
were divided into three aliquots, two of which received either saponin (0.4 % 
final  concentration) or TX-100  (0.1% final  concentration). The samples 
were incubated at 4"C for 30 min, and then separated into supernatant and 
pellet fractions by centrifugation for 5 min at 12,300 g.  The supernatant 
and pellet fractions were TCA precipitated and immunoprecipitated with 
antiserum to CPY, API, and ALP. 
In Vitro Synthesis of  API 
In  vitro  transcription  of  the  APE/  gene  was  carried  out  using  the 
pKK4/APE/construct described above. The transcription reaction was car- 
ried out essentially as described (Melton et al., 1984) using 5 t~g of DNA 
linearized with HindIII. In vitro translation of the mRNA from the tran- 
scription reaction was performed using wheat germ lysate as previously de- 
scribed (Theg et al.,  1989).  Tran3SS-label was substituted for 3H-leucine. 
Nondenaturing Polyacrylamide Gel Electrophoresis 
and Aminopeptidase Activity Staining 
Soluble yeast  extracts  were  prepared  as  described previously  (Garcia- 
Alvarez et al.,  1991). Extracts were electrophoresed under nondenaturiag 
conditions as described by Davis 0964) using a 4 % stacking gel and a 7.5 % 
separating gel.  The gels were stained for aminopeptidase activity as de- 
scribed (Hirsch et al.,  1988),  with Loleucine ~-naphthylamide as the sub- 
strate. 
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strains.  Soluble protein extracts were prepared from strains con- 
taining the indicated aminopeptidases.  The extracts were electro- 
phoresed under nondenaturing conditions and stained for activity 
using L-leucine/~-naphthylamide as the substrate  as described  in 
Materials  and Methods.  The strains and their relevant genotypes 
are as follows: (lane 1) SEY6210, APE/; (lane 2) DYY101, Aapel; 
(lane 3) DYY101/pRN1, Aapel/APE/; (lane 4) NAYIII-1, lap1 lap2 
lap3 (APE/);  (lane 5) NAYII-17, lap1 lap2 lap3 lap4 (ape1). 
Results 
Biosynthesis and Processing of  Aminopeptidase I 
Subsequent to the initial characterization of API as a vacuo- 
lar protein, little work has been done to examine the biogene- 
sis of this hydrolase. In part, this may have been due to the 
identification  of API as  a  glycoprotein (Metz  and  R6hm, 
1976)  that  was  processed  in  a  PEP4-dependent manner 
(Trumbly and Bradley,  1983); these results suggested that it 
was delivered to the vacuole by a process that was essentially 
the same as that used by the other well-studied soluble vacuo- 
lar hydrolases. The presence of an amino terminus that bears 
no resemblance to the  standard  signal sequence,  however, 
suggested a unique mechanism for ER translocation and/or 
vacuolar delivery  (Chang  and  Smith,  1989;  Cueva et al., 
1989). 
To examine the biosynthesis of this enzyme more carefully, 
we  generated  antiserum  to  API  using  synthetic  peptides 
based on the deduced amino acid sequence of the APE/gene. 
To characterize this antiserum, we constructed a yeast strain 
deleted for the chromosomal APE/  gene.  A  strain deleted 
and disrupted at the APE/locus,  DYY101  (Aapel::LEU2), 
was constructed by standard techniques as described in Ma- 
terials and Methods (Fig. 1). We prepared soluble protein ex- 
tracts from strain DYY101 and the isogenic wild-type strain. 
The extracts were electrophoresed under nondenaturing con- 
ditions and stained for aminopeptidase activity. Three of the 
four  leucine  aminopeptidase  activities,  corresponding  to 
aminopeptidases I, II, and IV, are easily observed in a wild- 
type strain (Fig. 2). Only the band corresponding to API is 
detected in purified vacuoles (data not shown) in agreement 
with the previously reported localization of this hydrolase 
(Matile et al.,  1971; Frey and R6hm, 1978).  Strain DYY101 
lacks the band representing API activity. When this strain is 
transformed with a plasmid encoding the APE/gene, the API 
activity band is restored. These activity data confirm that we 
have disrupted the APE/  locus in strain DYY101. 
We  analyzed  the  peptide-specific  antiserum  in  strain 
DYY101, as well as lap mutant strains derived from the origi- 
nal aminopeptidase mutants of Trumbly and Bradley (1983). 
The antiserum is able to precipitate two bands from a wild- 
type  strain  that  are  not  recognized  by preimmune  serum 
(Fig.  3).  These bands have an apparent molecular mass of 
~50 and 61 kD. The size of the lower molecular mass spe- 
cies is in agreement with the predicted size of mature API 
based on the deduced amino acid sequence of the APE/gene 
and is the same as that reported previously (Metz and R6hm, 
1976;  Chang and Smith, 1989). The more slowly migrating 
band runs at a higher molecular mass than is predicted for 
the precursor form of API (57 kD) based on the deduced 
amino acid sequence (Chang and Smith,  1989). A 61-kD in 
vitro translation product for API, however, was previously 
reported (Distel et al.,  1983).  The two bands show a time- 
Figure 3. Immunoprecipitation  of API from wild-type and mutant yeast strains and in vitro transcription/translation  reactions. Complete 
genotypes of the strains are listed in Table I. Cells were labeled for 40 min followed by a nonradioactive chase for 0 or 60 min as indicated. 
Radiolabeled cell extracts were immunoprecipitated with antiserum to API as described in Materials and Methods. The in vitro transcription 
and translation reactions were performed as described in Materials and Methods. The positions of  precursor and mature API and the position 
of protein  standards  (molecular  weight  ￿  103) are shown.  Immunoprecipitation  with preimmune  serum gave identical  results to that 
shown for strain DYY101 (lanes 3 and 4). The band that runs just below mature API is due to nonspecific cross-reacting material.  The 
strains used, the relevant phenotypes,  and the corresponding lane numbers are as follows: (lanes 1 and 2) SEY6210, API+; (lanes 3 and 
4) DYY101, API-; (lanes 5 and 6) DYY101/pRN1, API-/API+; (lane 7) SEY2101Apep4, API  + PrA-;  (lane 8) BJ3044,  API  + PrB-; (lanes 
9 and 10) NAYIII-I, API  § APII-IV-; (lanes 11 and 12) NAYII-17, API-IV-; (lane 13) in vitro API; (lane 14) BJ3044,  API  + PrB-. 
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the higher molecular mass form is seen in a pep4 mutant 
strain (Fig. 3). This is consistent with the known dependence 
of API activity on the PEP4 gene (Trumbly and Bradley, 
1983)  and indicates that this slowly migrating band is the 
API precursor. The additional molecular mass does not seem 
to be accounted for by carbohydrate (see below), so we sug- 
gest a  slightly aberrant migration. 
Neither of these bands is seen in strain DYY101, that is dis- 
rupted at the chromosomal APE/locus (Fig. 3). When strain 
DYY101 is transformed with a plasmid encoding the APE/ 
gene, both bands are again detected. In addition, when API 
is immunoprecipitated from a strain transformed with a mul- 
tiple copy (2# circle) plasmid encoding APE/, higher levels 
of API are detected (Fig. 4). These results suggest that the 
antiserum specifically recognizes the products of the APE/ 
gene.  The  API  immunoprecipitated from a prbl  mutant 
strain migrates at the position of the API precursor seen in 
a pep4 mutant strain (Fig. 3).  This suggests that PrB is the 
enzyme that is directly involved in the proteolytic maturation 
of API; the absence of API activity in a pep4 mutant strain 
is due to the block in PrB maturation (Hemmings et al., 
1981; Moehle et al., 1989) and not the absence of PrA per se. 
Yeast strain NAYII-17 lacks the four characterized leucine 
aminopeptidase activities (Trumbly and Bradley, 1983; Fig. 
2). In agreement with this, we detect no mature API in this 
strain by radiolabeling and immunoprecipitation (Fig.  3). 
The API precursor is seen in strain NAYII-17, but it appears 
to be slowly degraded without being converted into the ma- 
ture form. The APE/mutation in this strain has not been 
characterized and may be a missense mutation that renders 
the protein inactive and unstable. Strain NAYIII-1 is similar 
to strain NAYII-17 in lacking all of the leucine aminopepti- 
dase activities except for API  (Fig.  2).  As  expected,  an 
immunoprecipitation of this strain reveals the presence of 
both API bands (Fig. 3). This further confirms that we are 
specifically detecting API and not the other leucine amino- 
peptidases present in S.  cerevisiae. Finally, the antiserum 
specifically immunoprecipitates the primary product from an 
in vitro transcription/translation reaction carried out using 
mRNA prepared from a construct containing the APE/gene 
(Fig. 3). 
In a wild-type strain, there is a time-dependent appearance 
of the lower molecular weight API species concomitant with 
the disappearance of the higher molecular weight form, sug- 
gesting a precursor-product relationship (Fig. 3). To better 
characterize this relationship, we examined the processing 
kinetics of API. Pulse-chase labeling of wild-type yeast cells 
indicates that API is processed to the mature form with a 
half-time of approximately 45 min (Fig. 4). The same result 
was seen with wild-type cells containing a single-copy plas- 
mid encoding APE/.  This is in contrast to the processing 
half-time of '~6 rain seen for CPY (Fig. 4), PrA, or ALP 
(Hasilik and Tanner, 1978a; Klionsky et al., 1988; Klionsky 
and Emr,  1989). 
Arainopeptidase I Is Not Glycosylated 
All of the soluble vacuolar hydrolases that transit through the 
secretory pathway undergo some form of glycosyl modifica- 
tion  (Klionsky et  al.,  1990).  Core  oligosaccharides are 
added in the ER, and these are subsequently modified and 
elongated during passage through the Golgi complex. These 
glycosyl modifications result in molecular weight changes 
that are easily detectable by SDS-PAGE.  CPY, for example, 
is first detected as the ER glycosylated  (pl) form. Subsequent 
modifications within the Golgi complex generate the higher 
molecular weight (p2)  form of the enzyme (Stevens et al., 
1982; Zubenko et al., 1983; Fig. 4). API has four potential 
sites for the addition of N-linked oligosaccharides. Two of 
the sites have the less frequently used Asn-X-Ser  sequence 
(Moehle et al.,  1987),  so it is expected that glycosylation 
might only occur at two of the four sites.  No  molecular 
weight shift is seen with API, however,  other than the de- 
crease in molecular weight due to removal of the propeptide 
(Fig. 4). 
The lack of an observable molecular weight shift in the 
precursor form of API (Fig. 4) coupled with the observation 
that the product from an in vitro transcription/translation 
reaction comigrates with the precursor protein synthesized 
in  vivo  (Fig.  3)  suggests  that  the  protein  may  not  be 
glycosylated. To examine this further, we tested for the pres- 
ence of  N-linked and O-linked carbohydrates on API through 
the use of tunicamycin and Con A. Tunicamycin blocks the 
addition of N-linked oligosaccharides to proteins. After syn- 
thesis in the presence of tunicamycin, proteins that normally 
receive N-linked glycosylation migrate as lower molecular 
weight species during SDS-PAGE  relative to the untreated 
wild-type protein. Con A can be used to test for the presence 
of either N-linked or O-linked glycosylation because either 
type of oligosaccharide can bind to this lectin. Both types of 
analysis indicate that API is not glycosylated. 
Yeast cells were labeled with Tran35S-label for 30 min, in 
the presence or absence of tunicamycin. The cells were then 
subjected to a nonradioactive chase for 0 or 120 min. Sam- 
pies were removed at each time point, and half of each sam- 
ple was analyzed directly (total) by immunoprecipitation and 
gel electrophoresis. The remaining sample was treated with 
Con A  coupled to  sepharose,  and separated into Con A 
precipitable (pellet) and nonprecipitable (supernatant) frac- 
tions.  CPY contains four sites for N-linked glycosylation 
(Vails et al., 1987) and normally contains '~10,000 D of car- 
bohydrate (Hasilik and Tanner,  1978b).  In the presence of 
tunicamycin, CPY is not glycosylated  and migrates as lower 
molecular weight species (Hasilik and Tanner,  1978b;  Fig. 
5). Consistent with its being glycosylated, wild-type CPY is 
precipitable with Con A. CPY synthesized in the presence 
of tunicamycin, however, does not bind this lectin and is re- 
covered exclusively in the supernatant fraction (Fig. 5). In 
contrast, API does not show a decrease in molecular weight 
when synthesized in the presence of tunicamycin (Fig. 5). 
This suggests that it does not contain N-linked oligosaccha- 
rides.  In addition, API does not bind Con A either in the 
presence or absence of tunicamycin. Because proteins that 
contain either  N-linked or O-linked oligosaccharides are 
precipitable  with  Con  A,  this  suggests  that  API  is  not 
glycosylated. 
Treatment  with  tunicamycin is  nonspecific,  because  it 
blocks  the  glycosylation of all proteins  in  the  cell.  This 
results in secondary defects and tends to slow the transit of 
proteins  through  the  secretory  pathway  (Stevens  et  al., 
1982).  This can be seen by comparing the forms of CPY 
present at specific time points in the presence and absence 
of tunicamycin (Fig. 5). In the absence of tunicamycin, most 
of CPY is present as the mature form even at the 0-min 
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ther the single copy plasmid pRNI (A) or the multiple copy (2/~) 
plasmid pRCI (B) was labeled for 10 min and subjected to a non- 
radioactive  chase.  Aliquots were removed at the indicated times 
(min) and precipitated  with TCA. The samples were immunopre- 
cipitated with antiserum to API (A and B) or CPY (C) as described 
in Materials and Methods. The positions of precursor  and mature 
forms of API and CPY are indicated. Essentially identical results 
were obtained for strain SEY6210 and strain SEY6210 transformed 
with  the  plasmid  pRN1. (D)  Graphical  analysis  of the  autora- 
diograms  from A and B.  The closed boxes correspond  to SEY- 
6210/pRN1 (CENAPI), and the open boxes to SEY6210/pRC1 (2/z 
API). The percent  precursor values  are calculated  as precursor 
divided by precursor plus mature API at each time point. 
chase point.  By  120 min, all of the CPY is present as the 
mature form. After treatment with tunicamycin, a significant 
amount of precursor CPY remains even after  120  min of 
chase. In contrast, there is no detectable difference in the ki- 
netics of processing of API in the presence or absence of 
tunicamycin (Fig.  5). 
Aminopeptidase I Does Not Transit through the 
Secretory Pathway 
The absence of a  consensus  signal sequence,  the apparent 
lack of glycosylation,  and  the  relatively long half-time of 
maturation  suggest  that  API  may  not  transit  through  the 
secretory pathway. We addressed the issue of secretory path- 
way transit by examining the dependence of API processing 
on Sec proteins.  Mutations  in various SEC genes result in 
blocks in transit at different steps of the secretory pathway 
at the nonpermissive temperature (Esmon et al.,  1981; No- 
vick et al.,  1981).  The see12 and see23 mutants are blocked 
in ER to Golgi transport at the nonpermissive temperature 
and show a very rapid onset of the secretion defect (Kaiser 
and Schekman,  1990;  Graham and Emr,  1991;  Rexach and 
Schekman,  1991).  Yeast sec mutant strains were grown at 
23~  then shifted to a nonpermissive temperature of 37~ 
for 5  min to inactivate the altered SEC gene product.  The 
cells were then labeled for 5 min and subjected to a nonra- 
dioactive chase for 0-120 min at 34~  (Fig. 6). There is no 
processing of CPY even at the  120-min time point in the 
see23 mutant strain and only a small amount of mature CPY 
in the see12 mutant. Complete processing is seen in cells la- 
beled and chased at the permissive temperature. In contrast, 
there is substantial processing of AP! in both mutant strains 
at the nonpermissive temperature (Fig.  6).  Similar results 
were seen with see18 and sec7mutant cells (data not shown). 
In see1 mutant cells, there is also a partial block in API pro- 
cessing, although, in this case, there is complete maturation 
of CPY (data not shown). Because there is no indication that 
vacuolar hydrolases would transit through the late secretory 
pathway, this probably reflects general loss of viability of the 
sec mutant strains;  at the long chase times needed to  see 
complete maturation of API, the sec mutant strains are no 
longer competent for protein transport. This is similar to the 
result  seen  with  cr  (Yoshihisa  and  Anraku, 
1990). 
The relative see-independence  of API indicates  that the 
protein  does  not  enter  the  secretory  pathway.  This  is 
confirmed by a protease sensitivity analysis. Proteins that en- 
ter a  membrane-bound intracellular compartment are pro- 
tected from degradation by exogenous protease after gentle 
lysis of the plasma membrane. In contrast, cytoplasmic pro- 
teins are susceptible to proteolytic degradation under these 
conditions. API activity is localized to the vacuole but previ- 
ous studies have not addressed the location of the precursor 
protein.  It is possible that  the  precursor is  located  in  the 
vacuole but is processed with very slow kinetics.  Because 
mature API, like other mature vacuolar hydrolases, is resis- 
tant to proteolysis, it is not possible to determine the location 
of the mature enzyme by protease protection studies in a wild 
type strain. To further assess the location of precursor API, 
spheroplasts  were  prepared  from  strain  SEY2101Apep4, 
which  accumulates  only  the  precursor  form  of  API. 
Spheroplasts were labeled for 20 min and subjected to a non.. 
radioactive chase for either 2  or  135  min.  At each chase 
point, the samples were gently lysed with DEAE-dextran as 
described in Materials and Methods. 
Lysis with DEAE-dextran preserves the  integrity of the 
ER  and  Golgi  complex  as  well  as  that  of  the  vacuole 
(Klionsky and Emr, 1989). The lysed samples were divided 
into three aliquots and treated with pronase in the presence 
and absence of detergent (Fig. 7). At the 2-min chase point, 
both the pl and p2 forms of CPY are present. These precur- 
The Journal of Cell Biology, Volume 119, 1992  292 Figure 5. API does not bind Con A and is insensitive to tunicamycin. Wild-type strain SEY2101 was treated with tunicamycin (final concen- 
tration of 20/zg/ml) to inhibit glycosylation 15 min before the addition of Tran 3~S-label as indicated.  Labeling was allowed to continue 
for 30 min followed by a 0- or 120-min chase.  Samples were TCA precipitated  and divided in half.  One half was immunoprecipitated 
immediately with antiserum to API or CPY to give a total sample. The remaining half was precipitated with Con A-sepharose and separated 
into supernatant (not bound to Con A) and pellet (bound to Con A) fractions as described in Materials and Methods. The separate fractions 
were then immunoprecipitated  with antiserum  to API and CPY. The positions of precursor  and mature CPY and API and the position 
of protein standards  (molecular weight  x  103) are shown. T, total sample;  S, supernatant  from Con A; P, pellet from Con A. A and B 
show immunoprecipitations  of CPY from cells labeled in the absence (A) or presence (B) of tunicamycin. C and D show immunoprecipita- 
tions of API from cells labeled in the absence  (C) or presence  (D) of tunicamycin. 
sors are resistant to exogenous protease in the absence of de- 
tergent, indicating that they are protected within the ER and 
Golgi. At the 135-min chase point, all of the CPY would be 
expected to have entered the vacuole and is seen as the p2 
form because the vacuoles lack processing activity. This p2 
precursor is also protected from exogenous protease in the 
absence of detergent indicating that the vacuoles are intact. 
In contrast, the API precursor present after a 20-min label 
and 2-min chase is almost completely degraded to the size 
of mature API by added protease in the presence or absence 
of detergent.  This  indicates  it  is  not  inside  a  membrane- 
bound compartment, such as the vacuole. In contrast, at the 
135-rain  time point essentially all of the API precursor is 
now in a compartment, presumably the vacuole, that protects 
it from exogenous protease. 
The small amount of resistant API precursor seen at the 
2-min chase point most likely represents incomplete lysis of 
the  spheroplasts  by  DEAE-dextran.  This  is  supported  by 
analyzing the susceptibility of ALP to exogenous protease. 
The cytoplasmic portion of ALP is accessible to exogenous 
protease  in  lysed  spheroplasts  when  the  intracellular  or- 
ganelles  are  intact  (Klionsky  and  Emr,  1989).  Approxi- 
mately 20% of ALP remained insensitive to protease at the 
2-min chase point (data not shown).  This implies that one- 
fifth of the spheroplasts did not lyse under these conditions. 
These  results  indicate  that  at  early  time  points  the  API 
precursor is not within a membrane-enclosed compartment. 
This suggests that the precursor form of API resides in the 
cytoplasm and is translocated directly into the vacuole. 
Vacuolar Targeting of  Aminopeptidase I in vps Mutants 
IfAPI remains in the cytoplasm after it is synthesized, it may 
not be affected by vacuolar protein sorting (vps) mutants that 
were selected on the basis of secreting vacuolar proteins that 
transit through the secretory pathway (Bankaitis et al., 1986; 
Rothman and Stevens, 1986; Robinson et al., 1988; Rothman 
et al.,  1989).  We examined the localization and processing 
of API in several representative vps mutant strains.  Wild- 
type and vps mutant cells were labeled for 20 min and sub- 
jected to a  120-rain chase. The cultures were separated into 
cell (pellet) and media (supernatant) fractions after centrifu- 
gation,  and  analyzed  by  immunoprecipitation  and  SDS- 
PAGE (Fig. 8). In general, processing of API is more com- 
plete in the vps mutant strains than is seen for CPY and PrA. 
For example, vpsS, vps8, and vpsl7show substantial matura- 
tion of API even though these mutants are extremely defec- 
tive for processing CPY (Fig.  8) and PrA (Robinson et al., 
1988).  Many  of  the  vps  mutants,  however,  accumulate 
precursor API relative to a wild-type strain.  The band that 
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tracellular  compartment.  Spheroplasts were prepared  from strain 
SEY2101Apep4, labeled for 20 min, and subjected to a nonradio- 
active chase for 2 or 135 min. The spheroplasts were gently lysed 
with DEAE-dextran and treated with pronase and/or TX-100 as de- 
scribed in Materials and Methods. After TCA precipitation,  sam- 
pies were immunoprecipitated with antiserum to CPY or API. The 
positions of precursor and mature forms of CPY and API are indi- 
cated. 
Figure 6. Processing of aminopeptidase I is sec-independent. Tem- 
perature sensitive sec12 (A) or sec23 (B) mutant strains were grown 
to mid-log phase at 23~  and half of each culture was shifted to 
37~  for 5 min. Both strains were labeled for 5 min at 23~  or 34~ 
as indicated, and then chase was initiated by the addition of  methio- 
nine/cysteine as described in Materials and Methods. Samples were 
removed at the indicated times (min), TCA precipitated,  and then 
immunoprecipitated  with antiserum  to CPY or API. Essentially 
identical results as those shown for the sec23 mutant strain were 
seen with a secl mutant strain. The positions of precursor and ma- 
ture forms of CPY and API are shown. 
runs below precursor API seen in certain of the vps mutant 
strains is a degradation product (data not shown). It is not 
known if this species represents an intermediate in the nor- 
mal processing pathway. 
The vps mutant defects result in the secretion of the soluble 
vacuolar hydrolases CPY (Fig.  8),  PrB, and PrA (data not 
shown;  Robinson et al.,  1988),  as seen by the presence of 
precursor forms in the medium fraction. API is not seen in 
the extracellular fraction, however, from any of the vps mu- 
tants. The absence of API from the media fractions is only 
meaningful  if it  is  a  soluble  protein;  membrane proteins 
would always remain associated with the cell pellet. API is 
reported  to  be a  soluble  hydrolase,  but  the  apparent dis- 
crepancy with regard to glycosylation indicated that further 
studies with regard to solubility were necessary. To simplify 
this analysis, we prepared spheroplasts from sec18 mutant 
cells (blocked in ER to Golgi transit) and labeled them at the 
nonpermissive temperature. This resulted in the production 
of  only the ER form of  CPY and the vacuolar membrane pro- 
tein ALP. After labeling and chase, the spheroplasts were os- 
motically lysed and incubated with saponin or TX-100. The 
samples were separated into supernatant and pellet fractions 
by centrifugation and analyzed by immunoprecipitation. 
In the absence of detergent, rv70% of CPY remains in the 
pellet fraction (Fig. 9). The 30%  that was recovered in the 
supernatant fraction indicates that there was some lysis of the 
ER. In contrast,  85-90%  of precursor ALP was recovered 
in the membrane pellet fraction. Under the same conditions, 
~95 % of API was present in the supernatant fraction (Fig. 
9).  Treatment with the detergent saponin released virtually 
all of the CPY into the supernatant fraction by permeabiliz- 
ing the ER membrane. As before, almost all of API was also 
present in this fraction.  Saponin does not solubilize mem- 
brane proteins, and ALP remained associated with the mem- 
brane  fraction  (Schauer  et  al.,  1985;  Klionsky and  Emr, 
1989).  Disruption of the membranes with the nonionic de- 
tergent TX-100 resulted in the complete solubilization of all 
three hydrolases (Fig. 9). These results indicate that API is 
a  soluble protein. 
Translocation of  Aminopeptidase I into the Vacuole 
Utilizes a Saturable Component 
The primary evidence that suggests that vacuolar proteins 
are delivered to the vacuole by a receptor-mediated process 
is the observation that overproduction leads to precursor ac- 
cumulation and missorting to the cell surface (Rothman et 
al.,  1986;  Stevens et al.,  1986).  To examine the  effect of 
overproduction on the localization of vacuolar proteins, cells 
were transformed with multiple copy (2/~ circle) plasmids 
that  overproduce certain  of the  soluble  hydrolases.  Cells 
were labeled for 30 min followed by a 90-min chase. The cul- 
tures were separated into cell and  medium fractions,  and 
analyzed by immunoprecipitation. Cells harboring plasmids 
that overproduced either CPY or PrA showed precursor ac- 
cumulation and secretion of the respective hydrolase (Fig. 
10).  Synthesis from the plasmid pRN1 results in API levels 
approximately five times higher than that seen from the chro- 
mosome. This level of overproduction has no effect on the 
processing kinetics of API (Fig. 4). The multiple copy plas- 
The Journal of Cell Biology, Volume 119,  1992  294 Figure 8.  The API precursor is not secreted  from vps mutant ceils.  Wild-type (SEY6210) and vps mutant yeast strains  were labeled  for 
20 min and subjected to a nonradioactive chase for 0 or 120 min in the presence of BSA and a2-macroglobulin to reduce nonspecific  pro- 
teolysis.  The cultures  were separated  into cell (C) and medium (M) fractions  by centrifugation  and immunoprecipitated with antiserum 
to CPY and API. The positions  of precursor and mature forms of CPY and API are shown. 
mid pRC1  results  in  API levels  approximately  15-20-fold 
above the chromosomal level. Even with this increase in API 
production, none of the protein is secreted into the extracel- 
lular fraction (Fig.  10). This further supports the notion that 
API does not transit through the secretory pathway, because 
overproduction is not expected to cause secretion of a non- 
secretory pathway protein. 
If translocation  of API involves  a  limiting  component, 
however,  overproduction  would  be  expected  to  affect  the 
half-time of maturation.  We compared the kinetics of pro- 
cessing of API through a pulse-chase analysis of cells har- 
boring single or multiple copy APE1 plasmids.  API synthe- 
sized from the chromosome or the single copy plasmid pRN1 
has a processing half-time of •45  min (Fig. 4). Overproduc- 
tion of API from the plasmid pRC1  increases the half-time 
of processing to ~105 min (Fig. 4).  This increased level of 
API had no effect on the sorting of CPY. This suggests that 
some component required for translocation of API into the 
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Figure  9.  The  API precursor is  a  soluble  cytoplasmic protein. 
Spheroplasts  were prepared from strain  SEY5187 (sec18),  shifted 
to 37~  for 15 rain, then labeled and subjected to a nonradioactive 
chase for 30 min at 32~  The spberoplasts  were lysed and treated 
with saponin (0.4%)  or TX-100 (0.1%) as indicated.  The samples 
were  separated  into  soluble  (supernatant)  and  membrane-asso- 
ciated (pellet) fractions as described in Materials and Methods. The 
percent of each protein present in the supernatant fraction is calcu- 
lated  as the  ratio  of protein present  in the  supernatant  fraction 
divided by the total present in both the supernatant and pellet frac- 
tions combined, o, CPY;  I, API; ~a, ALP. 
Figure 10.  Overproduction of API does not result in its secretion 
from the cell.  Yeast cells were transformed with single or multiple 
copy plasmids  carrying the gene coding for API or multiple  copy 
plasmids carrying the gene coding for either CPY or PrA. The cells 
were labeled  for 30 min and subjected to a nonradioactive chase 
for 90 min. The samples were separated into cell (C) and medium 
(M) fractions by centrifugation and immunoprecipitated with anti- 
serum to API, CPY, or PrA. The positions of  precursor and mature 
forms of each hydrolase are shown. The genes (in parentheses)  car- 
ried by the respective plasmids and the proteins they encode are as 
follows:  (A) pRN1  (APE/),  API;  (B)  pRC1  (APE/),  API;  (C) 
pTSYI (PRCI), CPY;  (D) pPA3 (PEP4), PrA. 
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could indicate that the  processing  reaction itself is  rate- 
limiting.  Approximately 30-35%  of the  API  synthesized 
from pRC1, however, remains in the precursor form even af- 
ter extremely long chase points. The labeling and chase con- 
ditions were carried out as described in Materials and Meth- 
ods such that the cells were actively growing over the entire 
chase period (data not shown). Cell death then cannot ac- 
count for the lack of processing. The precursor that remains 
after 4 h or more of chase probably has not entered the vacu- 
ole. This precursor may be missorted into another compart- 
ment or  may be  folded into a  translocation incompetent 
form. 
The vacuolar protein ~x-mannosidase is thought to translo- 
cate into the vacuole from the cytoplasm (Yoshihisa and An- 
raku, 1990). API and ot-mannosidase  may use the same com- 
ponent(s) for vacuolar delivery. To gain additional insight 
into this mechanism of vacuolar import, we examined the 
effect of overproducing c~-mannosidase on the processing of 
API.  Synthesis of ct-mannosidase from the multiple copy 
plasmid pAM1  results in an •20-fold  increase in activity 
(Kuranda and Robbins, 1987).  This level of overproduction 
of ct-mannosidase resulted in an increase in the half-time of 
processing of API to ,x,65 min, whereas there was no effect 
on the kinetics of CPY  maturation (data not shown).  In 
this case, even though the half-time of processing was sig- 
nificantly increased, all of the precursor API was eventually 
processed to the mature form. 
Discussion 
In recent years, considerable attention has focused on the 
mechanisms used to accurately and efficiently sort proteins 
to specific organelles within eukaryotic cells. For many rea- 
sons, the yeast vacuole has been at the center of much of this 
research. The vacuole is relatively easy to purify biochemi- 
cally, contains a  large number of marker proteins, and is 
physiologically important to the cell (reviewed in Klionsky 
et al., 1990).  The targeting process for many vacuolar pro- 
teins is also a complex one; proteins entering the secretory 
pathway must be selectively retained at, or transit through, 
a large number of compartments. The factors involved in the 
final sorting decision that appears to occur at the trans Golgi 
network (Griffiths and Simons, 1986; Pfeffer and Rothrnan, 
1987)  remain largely undefined. At this time, there is no 
definitive evidence  that  vacuolar  proteins  utilize  protein 
receptors in the delivery process.  Similarly, even though a 
number  of genes  encoding  vacuolar  proteins  have  been 
cloned and sequenced, little progress has been made in iden- 
tifying the specific nature of vacuolar sorting signals. 
Current evidence  suggests that  soluble and  membrane 
vacuolar proteins that transit through the secretory pathway 
may use different sorting components (Banta et al.,  1988; 
Robinson et al., 1988; Klionsky and Emr, 1989, 1990; Her- 
man et al.,  1991). The precise mechanisms of sorting may 
also differ with respect to these two different classes of pro- 
teins. Soluble proteins are dependent on compartment acidi- 
fication for efficient vacuolar delivery, whereas membrane 
proteins are localized to the vacuole relatively independent 
of changes in lumenal pH (Banta et al.,  1988;  Klionsky et 
al.,  1992).  Analyses of c~-mannosidase  indicate that some 
resident proteins may get to the vacuole by a  completely 
different mechanism. This protein appears to enter the vacu- 
ole directly from the cytoplasm (Yoshihisa  and Anraku, 
!990). Other proteins may be translocated directly into the 
vacuole as part of catabolite inactivation (Funaguma et al., 
1985; Chiang and Schekman, 1991). This may be similar to 
the lysosomal import of certain cytosolic proteins destined 
for degradation (Dice,  1987; Chiang and Dice,  1988).  At 
present, there are no examples of resident lysosomal proteins 
that enter this organelle in an analogous manner. 
Many differences exist regarding the specific modifica- 
tions that occur on vacuolar proteins (Klionsky et al., 1990). 
A carefifl analysis makes it clear that no single protein can 
serve as a comprehensive model for vacuolar protein biogen- 
esis; there are significant variations with regard to proteo- 
lytic  processing  and  glycosylation.  Nonetheless,  certain 
vacuolar proteins have been instrumental in the elucidation 
of the transport process. CPY has served as a useful model 
of a soluble vacuolar protein that transits through the secre- 
tory pathway (Stevens  et al.,  1982;  Bankaitis et al.,  1986; 
Rothman and Stevens,  1986;  Johnson et al.,  1987; Vails et 
al., 1987). Similarly, alkaline phosphatase has many charac- 
teristics that make it a useful model for vacuolar membrane 
proteins (Klionsky and Emr,  1989).  The key features of a 
useful marker protein for following protein sorting are that 
it undergo glycosyl modification and/or proteolytic process- 
ing.  These processes allow a rapid and specific determina- 
tion of the location of the protein within the cell. In particu- 
lar, glycosyl modifications allow an assessment of a protein's 
position within the secretory pathway, whereas proteolytic 
removal of a propeptide is a convenient means to kinetically 
follow vacuolar delivery. 
Similarly, to understand the mechanism involved in an al- 
ternative, nonsecretory pathway, vacuolar targeting process, 
it is necessary to have useful marker proteins. At present, 
only two resident vacuolar proteins have been shown to use 
this alternative pathway: ot-mannosidase and API. For vari- 
ous  reasons,  a-mannosidase is  not likely to  be  a  useful 
marker  protein.  The  half-time  of processing  of API  is 
significantly longer than that of secretory pathway mediated 
vacuolar protein delivery, but it occurs within a time frame 
that is technically useful. In contrast, the half-time of pro- 
cessing for ot-mannosidase is ,x,10 h (Yoshihisa and Anraku, 
1990),  making a kinetic analysis of vacuolar delivery dif- 
ficult to follow. In addition, u-mannosidase is not expressed 
well unless cells are heat shocked at 37~  (Yoshihisa and An- 
raku,  1990).  Analyses of mRNA levels  indicate that API 
synthesis increases as cells approach stationary phase and 
when the  glucose concentration decreases  (Distel  et  al., 
1983;  Cueva et al.,  1989).  The protein is easily detected, 
however, during logarithmic growth. Because of these char- 
acteristics, API will be a useful marker protein to follow 
vacuolar delivery through this alternate mechanism. 
The lack of a consensus signal sequence in API makes it 
unclear how this protein would enter the ER.  The initial 
characterization of API suggested that it is a glycoprotein 
(Metz and Rfhm, 1976) but the present studies indicate that 
this is not correct. Several observations suggest that this pro- 
tein does not in fact enter the secretory pathway: (/) the rela- 
tively long half-time for processing of API; (2) the lack of 
glycosylation; (3)  Sec  protein  independence;  (4)  lack of 
secretion from vps mutants or upon overproduction. Precur- 
sor API appears to remain in the cytoplasm after synthesis. 
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ER and Golgi precursor forms of CPY are protected. These 
results suggest that API first enters a  membrane-enclosed 
compartment posttranslationally. 
Processing of API is relatively independent of the SEC 
gene products. Precursor API is not completely processed at 
the nonpermissive temperature, however,  in any of the sec 
mutant strains examined. We believe this reflects the rela- 
tively long half-time required for API processing coupled 
with a reduced viability of sec mutant strains under nonper- 
missive conditions. Most of the sec mutant strains display a 
reversible temperature-dependent phenotype; transit of ac- 
cumulated proteins proceeds  after return to a  permissive 
temperature (Novick et al.,  1980).  The precursor API that 
accumulated in the sec mutants at the restrictive temperature 
was  not processed,  however,  even after an additional 2-h 
chase following a return to the permissive temperature (data 
not shown). In addition, API shows a level of processing in 
a  secl  mutant strain similar to that seen in the sec12  and 
sec23 mutants. It is unlikely that delivery of API to the vacu- 
ole is dependent on components of  the late secretory pathway 
such as the Secl protein. The partial block in API processing 
exhibited by all of the sec mutant strains probably reflects 
cell inviability of these strains resulting from extended ex- 
posure to elevated temperatures. This indicates a limitation 
in the use of the sec mutant strains when examining proteins 
such as API that have long half-times for processing. 
Although API does not appear to be sensitive to sec muta- 
tions,  it is affected by vps  mutants.  The accumulation of 
precursor API in vps mutants suggests four possibilities: (/) 
API may share some sorting components encoded by certain 
lIPS genes that are used by vacuolar proteins that transit 
through the secretory pathway. (2) The vacuole in many vps 
mutant strains may not be a competent target for vacuolar 
delivery. In particular, the class C vps mutants, such as vps16 
in Fig. 8, lack a detectable vacuole (Banta et al.,  1988) so 
it is not surprising that API cannot be processed.  These 
mutants also affect ot-marmosidase,  an observation that is 
consistent with these two proteins using the same import 
pathway (Banta  et  al.,  1988).  (3)  Severe  vps  missorting 
phenotypes also result in reduced levels of processing en- 
zymes being localized to the vacuole. This may lower the 
processing capacity of the organelle such that precursor API 
located within the vacuole may not be proteolytically ma- 
tured.  (4)  API may use a  receptor/translocator protein or 
some  other  component  that  is  delivered  to  the  vacuole 
through the secretory pathway. In vps mutants, delivery of 
this protein may be defective, resulting in inefficient import 
of API into the vacuole. This would be similar to the pro- 
posed sec-dependent  delivery of a vacuolar import protein 
required  for  translocation of fructose  1,6-bisphosphatase 
(Chiang and Schekman,  1991). If a  receptor/translocator 
protein is used, it may be saturable. Because API is not in 
the secretory pathway, it will not be secreted upon saturation 
of this component. Saturation would be expected to slow the 
half-time of  processing, and this is seen upon overproduction 
of API from a multiple copy plasmid. 
A  substantial amount of the API precursor is never ma- 
tured under conditions where it is overproduced. This may 
indicate that some level of the precursor is missorted. A 
more likely explanation for the lack of complete maturation 
upon overproduction is that one or more cytoplasmic compo- 
nents  such  as  an  hsp70  protein  (Chirico  et  al.,  1988; 
Deshaies  et  al.,  1988)  are  required  for maintaining the 
precursor in a translocation competent state. Overproduc- 
tion  titrates  out  this  component,  causing  the  remaining 
precursor to prematurely fold into a form that is no longer 
compatible to interact with the translocation machinery or 
is no longer competent to cross a membrane. This may be 
similar to the model proposed for the E. coli maltose binding 
protein (MBP) (Randall and Hardy, 1986).  If translocation 
of pre-MBP does not occur within a specific time-frame, the 
precursor protein folds into a conformation that is not longer 
competent for export. Folding of pre-MBP and maintenance 
of the  translocation  competent  form  may be  modulated 
through  interaction  with  the  molecular  chaperone  SecB 
(Kumamoto, 1991). 
Chaperonins or polypeptide chain binding proteins (Ellis, 
1987; Rothman, 1989) are involved in allowing proteins to 
translocate  across  membranes  by maintaining them  in  a 
partly unfolded state. In addition to some bacterial secreted 
proteins, this has been suggested for certain eukaryotic pro- 
teins  that  enter  mitochondria,  chloroplasts,  and  the  ER 
(reviewed in Ellis and van der Vies, 1991; Kumamoto, 1991; 
Zeilstra-Ryalls et al., 1991). Accessory proteins may also be 
needed for protein refolding after translocation is complete. 
The GRP78/BiP protein located within the ER lumen and the 
mitochondrial hsp60 protein, for example, have been impli- 
cated in the folding of translocated proteins  (Bole et al., 
1986;  Munro and Pelham,  1986;  Ostermann et al.,  1989). 
These molecular chaperones are often members of the heat 
shock family of stress  proteins  (Schlesinger,  1990;  Ellis 
and van der Vies,  1991). Heat shock proteins have been 
shown to be involved in the translocation of vacuolar pro- 
teins into the ER lumen (Deshaies et al., 1988). A member 
of the heat shock protein family has not been shown to play 
a role in the transport of vacuolar proteins directly into the 
vacuole, although an hsp70 protein has been implicated in 
the import of proteins destined for lysosomal degradation 
(Chiang et al., 1989). We are currently addressing the ques- 
tion of  whether API utilizes a molecular chaperone for trans- 
location into the vacuole. It is interesting to consider the pos- 
sibility that API also requires some type of binding protein 
within the vacuolar lumen to promote its proper folding after 
translocation. 
The  observation  that overproduction of a-mannosidase 
also increases the half-time of processing of API suggests 
that both proteins  may use a  common component in the 
translocation process.  The mechanisms of vacuolar import 
of the resident protein o~-mannosidase or a protein destined 
for degradation such as fructose 1,6-bisphosphatase  have not 
been elucidated. The entry of these proteins into the vacuole 
is difficult to follow because of the long half-times of pro- 
cessing and the lack of a  specific cleavage event, respec- 
tively. An analysis of API translocation may allow a detailed 
dissection of this alternate pathway. Certain features of the 
unique API amino terminus may be critical in allowing the 
translocation event to proceed. We are currently investigat- 
ing the location of the sorting signal of API. In addition, we 
have begun an in vitro analysis of API translocation into the 
vacuole in order to define trans-acting components required 
for vacuolar localization of this hydrolase. 
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